Description
The pandemic has proven a challenge to the entire apparatus of Global Health Governance, exposing both the weaknesses and the strengths of existing rules and conventions. One outcome of this is the realisation of a pressing need for more reliable instruments and structures of accountability in a sphere that is at the same time essentially global and also necessarily local in application. High-level debate includes the possible revision of existing mechanisms such as the International Health Regulations (IHR), the pivotal effects of declarations of a public health emergencies of international concern (PHEICs), the controversies arising around the issue of patent waivers, the dimensions of the role of the public-private-partnerships in health governance, and also the potential for a new global pandemic treaty. This panel delves deeply into these urgent questions for global health governance, and seeks to chart the implications for the course ahead.
